Search

Your search keyword '"Roberts, Lewis"' showing total 868 results

Search Constraints

Start Over You searched for: Author "Roberts, Lewis" Remove constraint Author: "Roberts, Lewis" Database Unpaywall Remove constraint Database: Unpaywall
868 results on '"Roberts, Lewis"'

Search Results

3. Contributors

5. Prognostication of ß-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy.

6. SAT-479-YI Lower frequency of PNPLA3 in african populations and divergent associations with hepatocellular carcinoma

7. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

13. Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts

14. Metabolome-Wide Association Identifies Altered Metabolites and Metabolic Pathways in the Serum of Patients with Cholangiocarcinoma

15. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

16. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma

17. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response

21. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

24. Africa Guidelines for Hepatocellular Carcinoma Buildup Process

25. The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma

27. Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection

28. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study

29. Fibrolamellar Carcinoma

30. Cholangiocarcinoma

31. Hepatocellular Carcinoma

32. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

33. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de‐palmitoylation

34. IMPACT OF ARTIFICIAL INTELLIGENCE-DRIVEN WHOLE SLIDE IMAGE SCORING AND PRIORITIZATION ON USER EFFICIENCY DURING CYTOLOGIC EVALUATION OF BILIARY STRICTURES

35. Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography

38. Mo1131 METHYLATED DNA MARKERS TO DIFFERENTIATE MALIGNANT FROM BENIGN BILIARY STRICTURES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

39. Trap and Ambush Therapy Using Sequential Primary and Tumor Escape-Selective Oncolytic Viruses

42. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

45. Supplementary Figure SF5 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

46. Supplementary Figure SF4 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

47. Abstract 6013: DNA methylation-based inflammation score is associated with hepatocellular carcinoma among people living with HIV

48. Supplementary Figure SF5 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

49. Supplementary Table ST2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

50. Supplementary Table ST2 from Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

Catalog

Books, media, physical & digital resources